Patents by Inventor Jason J. Benkoski

Jason J. Benkoski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210094255
    Abstract: Articles and insulating systems include a wicking layer, an incompressible insulation layer, and a water scavenging system comprising a superhydrophobic layer in operative communication with one or more water collecting components.
    Type: Application
    Filed: July 28, 2020
    Publication date: April 1, 2021
    Inventors: Jason J. Benkoski, Konstantinos Gerasopoulos, Steven M. Griffiths, Paul J. Biermann, Melanie L. Morris, Xiomara Calderon-Colon
  • Patent number: 10758630
    Abstract: A topical composition includes a nanoemulsion of a plurality of hydrophobic particles having a hydrophilic coating therein. The hydrophobic particles are derived from the same or different hydrophobic material and each hydrophobic particle has a melting point below the melting point of the respective hydrophobic material. The hydrophobic particles comprise a mean particle size of less than about 10 nm, and the nanoemulsion further includes one or more pharmaceutically active agents.
    Type: Grant
    Filed: September 19, 2012
    Date of Patent: September 1, 2020
    Assignee: The Johns Hopkins University
    Inventors: Jennifer L. Sample, Julia B. Patrone, Jason J. Benkoski, Jennifer L. Breidenich, Lisa A. Kelly, Huong Le, James C. Crookston, Marcia W. Patchan, Luis Garza, Xiomara Calderon-Colon, Joshua T. Wolfe, Mellisa L. Theodore, Amanda Nelson, Sewon Kang
  • Patent number: 10376682
    Abstract: Implantable pressure-actuated systems to deliver a drug and/or other substance in response to a pressure difference between a system cavity and an exterior environment, and methods of fabrication and use. A pressure-rupturable membrane diaphragm may be tuned to rupture at a desired rupture threshold, rupture site, with a desired rupture pattern, and/or within a desired rupture time. Tuning may include material selection, thickness control, surface patterning, substrate support patterning. The cavity may be pressurized above or evacuated below the rupture threshold, and a diaphragm-protective layer may be provided to prevent premature rupture in an ambient environment and to dissipate within an implant environment. A drug delivery system may be implemented within a stent to release a substance upon a decrease in blood pressure. The cavity may include a thrombolytic drug to or other substance to treat a blood clot.
    Type: Grant
    Filed: October 11, 2016
    Date of Patent: August 13, 2019
    Assignee: The Johns Hopkins University
    Inventors: Chao-Wei Hwang, Hala J. Tomey, Jon R. Resar, Robert C. Matteson, III, George L. Coles, Jr., Jason J. Benkoski, Morgana M. Trexler
  • Publication number: 20190031886
    Abstract: A coating system may be configured to be applied to an aluminum-magnesium substrate of an object. The coating system may include a primer configured to reduce the corrosion rate of the aluminum-magnesium substrate and a topcoat configured to resist water and improve solar reflectance of the coating system. The primer may include a silicate and a first additive configured to increase corrosion resistance of the coating system The topcoat may include a siloxane and a second additive configured to reduce solar absorptance of the coating system.
    Type: Application
    Filed: March 29, 2018
    Publication date: January 31, 2019
    Inventors: Jason J. Benkoski, Christopher M. Hoffman, JR., Rengaswamy Srinivasan, Keith S. Caruso
  • Publication number: 20170028181
    Abstract: Implantable pressure-actuated systems to deliver a drug and/or other substance in response to a pressure difference between a system cavity and an exterior environment, and methods of fabrication and use. A pressure-rupturable membrane diaphragm may be tuned to rupture at a desired rupture threshold, rupture site, with a desired rupture pattern, and/or within a desired rupture time. Tuning may include material selection, thickness control, surface patterning, substrate support patterning. The cavity may be pressurized above or evacuated below the rupture threshold, and a diaphragm-protective layer may be provided to prevent premature rupture in an ambient environment and to dissipate within an implant environment. A drug delivery system may be implemented within a stent to release a substance upon a decrease in blood pressure. The cavity may include a thrombolytic drug to or other substance to treat a blood clot.
    Type: Application
    Filed: October 11, 2016
    Publication date: February 2, 2017
    Inventors: Chao-Wei Hwang, Hala J. Tomey, Jon R. Resar, Robert C. Matteson, III, George L. Coles, JR., Jason J. Benkoski, Morgana M. Trexler
  • Patent number: 9550855
    Abstract: A metallic microcapsule containing a polymeric microcapsule having one or more polymeric precursors encapsulated therein; and a metallic shell enclosing a volume containing the polymeric microcapsule is disclosed. Also disclosed is a self-healing coating composition comprising (a) a film-forming binder; and (b) metallic microcapsules, the metallic microcapsules being the same or different and containing a polymeric microcapsule containing one or more polymeric precursors encapsulated therein; and a metallic shell enclosing a volume containing the polymeric microcapsule.
    Type: Grant
    Filed: April 11, 2011
    Date of Patent: January 24, 2017
    Assignee: The Johns Hopkins University
    Inventors: Jason J. Benkoski, Rengaswamy Srinivasan, Jeffrey P. Maranchi
  • Patent number: 9504586
    Abstract: Implantable pressure-actuated systems to deliver a drug and/or other substance in response to a pressure difference between a system cavity and an exterior environment, and methods of fabrication and use. A pressure-rupturable membrane diaphragm may be tuned to rupture at a desired rupture threshold, rupture site, with a desired rupture pattern, and/or within a desired rupture time. Tuning may include material selection, thickness control, surface patterning, substrate support patterning. The cavity may be pressurized above or evacuated below the rupture threshold, and a diaphragm-protective layer may be provided to prevent premature rupture in an ambient environment and to dissipate within an implant environment. A drug delivery system may be implemented within a stent to release a substance upon a decrease in blood pressure. The cavity may include a thrombolytic drug to or other substance to treat a blood clot.
    Type: Grant
    Filed: February 13, 2014
    Date of Patent: November 29, 2016
    Assignee: The Johns Hopkins University
    Inventors: Chao-Wei Hwang, Hala J. Tomey, Jon R. Resar, Robert C. Matteson, III, George L. Coles, Jr., Jason J. Benkoski, Morgana M. Trexler
  • Publication number: 20150217030
    Abstract: Certain embodiments according to the present invention provide a method for forming medical devices conformally coated with a hydrogel having a wide variety of therapeutic uses. In one aspect, certain embodiments of the invention provide a method for forming a hydrogel-coated medical device comprising immersing a medical device in a polymer solution to form an adhesive layer on an outer surface of the medical device and contacting the medical device with a hydrogel precursor solution having a pH of less than 7 to react the adhesive layer with the hydrogel precursor solution and form a conformal hydrogel coating.
    Type: Application
    Filed: February 5, 2015
    Publication date: August 6, 2015
    Inventors: Jason J. Benkoski, Peter V. Johnston, Chao-Wei Hwang, Gary Gerstenblith, Robert G. Weiss, Gordon Tomaselli, Steven P. Schulman, Jeffrey A. Brinker
  • Publication number: 20140188213
    Abstract: Implantable pressure-actuated systems to deliver a drug and/or other substance in response to a pressure difference between a system cavity and an exterior environment, and methods of fabrication and use. A pressure-rupturable membrane diaphragm may be tuned to rupture at a desired rupture threshold, rupture site, with a desired rupture pattern, and/or within a desired rupture time. Tuning may include material selection, thickness control, surface patterning, substrate support patterning. The cavity may be pressurized above or evacuated below the rupture threshold, and a diaphragm-protective layer may be provided to prevent premature rupture in an ambient environment and to dissipate within an implant environment. A drug delivery system may be implemented within a stent to release a substance upon a decrease in blood pressure. The cavity may include a thrombolytic drug to or other substance to treat a blood clot.
    Type: Application
    Filed: February 13, 2014
    Publication date: July 3, 2014
    Applicant: Johns Hopkins University
    Inventors: Chao-Wei Hwang, Hala J. Tomey, Jon R. Rosar, Robert C. Matteson, George L/ Coles, Jason J. Benkoski, Morgana M. Trexler
  • Patent number: 8696740
    Abstract: Implantable pressure-actuated systems to deliver a drug and/or other substance in response to a pressure difference between a system cavity and an exterior environment, and methods of fabrication and use. A pressure-rupturable membrane diaphragm may be tuned to rupture at a desired rupture threshold, rupture site, with a desired rupture pattern, and/or within a desired rupture time. Tuning may include material selection, thickness control, surface patterning, substrate support patterning. The cavity may be pressurized above or evacuated below the rupture threshold, and a diaphragm-protective layer may be provided to prevent premature rupture in an ambient environment and to dissipate within an implant environment. A drug delivery system may be implemented within a stent to release a substance upon a decrease in blood pressure. The cavity may include a thrombolytic drug to or other substance to treat a blood clot.
    Type: Grant
    Filed: January 5, 2011
    Date of Patent: April 15, 2014
    Assignee: The Johns Hopkins University
    Inventors: Chao-Wei Hwang, Hala J. Tomey, Jon R. Rosar, Robert C. Matteson, III, George L. Coles, Jr., Jason J. Benkoski, Morgana M. Trexler
  • Publication number: 20130017405
    Abstract: A microcapsule is disposed in a self-healing coating having zinc powder particles dispersed therein. The microcapsule includes at least a silane coupling agent encapsulated within a volume defined by a metallic or polymeric shell that is rupturable responsive to formation of a fissure in the self-healing coating.
    Type: Application
    Filed: August 23, 2012
    Publication date: January 17, 2013
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Jason J. Benkoski, Rengaswamy Srinivasan, Jeffrey P. Maranchi
  • Publication number: 20120039814
    Abstract: A topical composition includes a nanoemulsion of a plurality of hydrophobic particles having a hydrophilic coating therein. The hydrophobic particles are derived from the same or different hydrophobic material and each hydrophobic particle has a melting point below the melting point of the respective hydrophobic material. The nanoemulsion further includes one or more pharmaceutically active agents and/or one or more chemiluminescent disease-detecting systems.
    Type: Application
    Filed: August 12, 2011
    Publication date: February 16, 2012
    Inventors: Jennifer L. Sample, Julia B. Patrone, Jason J. Benkoski, James C. Crookston, Huong Le, Jennifer L. Breidenich, Lisa A. Kelly
  • Publication number: 20120010698
    Abstract: Implantable pressure-actuated systems to deliver a drug and/or other substance in response to a pressure difference between a system cavity and an exterior environment, and methods of fabrication and use. A pressure-rupturable membrane diaphragm may be tuned to rupture at a desired rupture threshold, rupture site, with a desired rupture pattern, and/or within a desired rupture time. Tuning may include material selection, thickness control, surface patterning, substrate support patterning. The cavity may be pressurized above or evacuated below the rupture threshold, and a diaphragm-protective layer may be provided to prevent premature rupture in an ambient environment and to dissipate within an implant environment. A drug delivery system may be implemented within a stent to release a substance upon a decrease in blood pressure. The cavity may include a thrombolytic drug to or other substance to treat a blood clot.
    Type: Application
    Filed: January 5, 2011
    Publication date: January 12, 2012
    Inventors: Chao-Wei Hwang, Hala J. Tomey, Jon R. Rosar, Robert C. Matteson, III, George L. Coles, JR., Jason J. Benkoski, Morgana M. Trexler
  • Publication number: 20110293958
    Abstract: A metallic microcapsule containing a polymeric microcapsule having one or more polymeric precursors encapsulated therein; and a metallic shell enclosing a volume containing the polymeric microcapsule is disclosed. Also disclosed is a self-healing coating composition comprising (a) a film-forming binder; and (b) metallic microcapsules, the metallic microcapsules being the same or different and containing a polymeric microcapsule containing one or more polymeric precursors encapsulated therein; and a metallic shell enclosing a volume containing the polymeric microcapsule.
    Type: Application
    Filed: April 11, 2011
    Publication date: December 1, 2011
    Inventors: Jason J. Benkoski, Rengaswamy Srinivasan, Jeffrey P. Maranchi
  • Publication number: 20100209516
    Abstract: A drug delivery system, product and method which effectuates delivery of appropriate amounts of a pharmaceutically active agent only upon stimulus of a physiological agent released during a disease event are described. A polymer that can bind to a specific biological stimulus and respond with a specific response is included. The response may be release of a pharmaceutical agent, an optical signal or a change in physical properties of the polymer. The design of associative polymers that are held together using temporary bonds which will dissolve, break apart or swell in the presence of the specific stimulus are described. One embodiment includes a reversible response to a biological stimulus.
    Type: Application
    Filed: February 9, 2010
    Publication date: August 19, 2010
    Inventors: Jason J. Benkoski, Andrew F. Mason, Lance M. Baird, Jennifer L. Sample